Your session is about to expire
← Back to Search
SURE vs. Standard Ureteroscopy for Kidney Stones
Study Summary
This trial will compare the two most common treatments for kidney stones.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have kidney stones.I am a candidate for a procedure to remove kidney stones using lasers.I can attend all required follow-up visits for the study.I have issues with my bladder, ureter, or kidneys.You have other serious health problems.You weigh more than what is considered healthy for your height.
- Group 1: Standard Ureteroscopy (Basketing)
- Group 2: SURE
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the geographic range of this experiment?
"Albany Medical College in Albany, New york and Prisma Health in Greenville, South carolina are two of the primary clinical trial locations for this study. Duke University in Durham, North carolina is a third notable site along with 10 other medical centres."
Does this trial permit those who are of legal age to participate?
"Consistent with the study's parameters, participants must be between 18 and 80 years old to qualify for inclusion."
Who meets the criteria to participate in this research?
"This clinical trial is recruiting 162 individuals with urolithiasis between the ages of 18 and 80. To be eligible for enrolment, patients must exhibit a willingness to attend all follow-up visits required by the study protocol."
How many participants are currently enrolled in this experiment?
"Calyxo, Inc. will oversee the execution of this trial across Albany Medical College and Prisma Health, both in need of 162 participants meeting predetermined inclusion criteria."
Is enrollment in this trial open at this time?
"Affirmative. According to the information logged on clinicaltrials.gov, this trial is still in need of participants and was initially posted on June 16th 2021. As of November 10th 2022, 162 patients are required from a span of 10 medical sites."
Share this study with friends
Copy Link
Messenger